Enthusiasm and Ethics

Emmanuelle Charpentier and Jennifer Doudna's interest in CRISPR stemmed from its role as a sort of bacterial immune system, but along the way, they realized that CRISPR and its enabling protein Cas9 could be combined into a single tool that could possibly work in a range of organisms, the New York Times Magazine reports.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

An opinion piece in the Guardian argues that President Donald Trump is uninterested in science and that might not be a bad thing for the field.

The San Francisco Chronicle reports the Veterans Affairs Health System is studying whether genetic testing can help prescribe better depression therapies.

Stat News reports that Spark Therapeutics' Luxturna is now being used to treat a wider array of patients.

In Genome Biology this week: transcription factor use among brittle stars, single-cell RNA sequencing strategy, and more.